Top

Published in:

Open Access 01-12-2017 | Letter to the Editor

A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry

Authors: Kathryn R. Napier, Megan Tones, Chloe Simons, Helen Heussler, Adam A. Hunter, Meagan Cross, Matthew I. Bellgard

Published in: Orphanet Journal of Rare Diseases | Issue 1/2017

Abstract

Angelman syndrome (AS) is a rare neurodevelopmental disorder that is characterised by severe global developmental delays, ataxia, loss of speech, epilepsy, sleep disorders, and a happy disposition. There is currently no cure for AS, though several pharmaceutical companies are anticipating drug trials for new therapies to treat AS. The Foundation for Angelman Therapeutics (FAST) Australia therefore identified a need for a global AS patient registry to identify patients for recruitment for clinical trials.

The Global AS Registry was deployed in September 2016 utilising the Rare Disease Registry Framework, an open-source tool that enables the efficient creation and management of patient registries. The Global AS Registry is web-based and allows parents and guardians worldwide to register, provide informed consent, and enter data on individuals with AS. 286 patients have registered in the first 8 months since deployment.

We demonstrate the successful deployment of the first patient-driven global registry for AS. The data generated from the Global AS Registry will be crucial in identifying patients suitable for clinical trials and in informing research that will identify treatments for AS, and ultimately improve the lives of individuals and their families living with AS.

Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15:70–3.CrossRefPubMed

Matsuura T, Sutcliffe JS, Fang P, Galjaard R-J, Y-h J, Benton CS, et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet. 1997;15:74–7.CrossRefPubMed

Angelman H. ‘Puppet’ children a report on three cases. Dev Med Child Neurol. 1965;7:681–8.CrossRef

Prokosch H, Beck A, Ganslandt T, Hummel M, Kiehntopf M, Sax U, et al. IT infrastructure components for biobanking. Appl Clin Inform. 2010;1:419–29.CrossRefPubMedPubMedCentral

Bird LM. Angelman syndrome: review of clinical and molecular aspects. Appl Clin Genet. 2014;7:93–104

Spruyt K, Braam W, Curfs LM. Sleep in Angelman syndrome: a review of evidence. Sleep Med Rev. 2017;

Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A. 2006;140:413–8.CrossRefPubMed

Bailus BJ, Segal DJ. The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders. BMC Neurosci. 2014;15:76.CrossRefPubMedPubMedCentral

Mertz LGB, Christensen R, Vogel I, Hertz JM, Nielsen KB, Grønskov K, et al. Angelman syndrome in Denmark. Birth incidence, genetic findings, and age at diagnosis. Am J Med Genet A. 2013;161:2197–203.CrossRef

10.

Bellgard MI, Beroud C, Parkinson K, Harris T, Ayme S, Baynam G, et al. Dispelling myths about rare disease registry system development. Source Code Biol Med. 2013;8:21.CrossRefPubMedPubMedCentral

11.

Bellgard MI, Render L, Radochonski M, Hunter A. Second generation registry framework. Source Code Biol Med. 2014;9:14.CrossRefPubMedPubMedCentral

12.

Bellgard MI, Napier K, Render L, Radochonski M, Lamont L, Graham C, et al. A registry framework enabling patient-Centred care. Stud Health Technol Inform. 2015;214:8–14.PubMed

13.

Lindoerfer D, Mansmann U. A comprehensive assessment tool for patient registry software systems: the CIPROS checklist. Methods Inf Med. 2015;54:447–54.CrossRefPubMed

14.

EUCERD. Core Recommendations on Rare Disease Patient Registration and Data Collection. 2013. http://www.eucerd.eu/wpcontent/uploads/2013/06/EUCERD_Recommendations_RDRegistryDataCollection_adopted.pdf. Accessed 15 Jan 2016.

15.

EURORDIS-NORD-CORD. Joint Declaration 10 Key Principles of Rare Disease Patient Registries. 2012. http://download.eurordis.org/documents/pdf/EURORDIS_NORD_CORD_JointDec_Registries_FINAL.pdf. Accessed 15 Jan 2016.

16.

Bellgard MI, Napier KR, Bittles AH, Szer J, Fletcher S, Zeps N et al. Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher Disease Registry model. Blood Cells Mol Dis 2017;In press.

17.

Bellgard MI, Walker CE, Napier KR, Lamont L, Hunter AA, Render L et al. Design of the Familial Hypercholesterolaemia Australasia Network Registry: creating opportunities for greater international collaboration. J Atheroscler Thromb 2017;In press.

18.

Napier KR, Pang J, Lamont L, Walker CE, Dawkins HJS, Hunter AA, et al. A web-based registry for familial hypercholesterolaemia. Heart Lung Circ. 2017;26:635–9.CrossRefPubMed

19.

Bellgard MI, Macgregor A, Janon F, Harvey A, O'Leary P, Hunter A, et al. A modular approach to disease registry design: successful adoption of an internet-based rare disease registry. Hum Mutat. 2012;33:E2356–E66.CrossRefPubMed

20.

The Global Angelman Syndrome Registry. https://angelmanregistry.info. Accessed 20 June 2017.

21.

Rare Disease Registry Framework GutHub Repository. https://github.com/muccg/rdrf. Accessed 20 June 2017.

22.

Rare Disease Registry Framework Project Page. https://muccg.github.io/rdrf/. Accessed 20 June 2017.

23.

Django. http://www.djangoproject.com. Accessed 20 June 2017.

24.

PostgreSQL. http://www.postgresql.org. Accessed 20 June 2017.

25.

YAML: YAML Ain't Markup Language. http://www.yaml.org. Accessed 20 June 2017.

26.

jQuery. jquery.com. Accessed June 20 2017.

27.

Bootstrap. getbootstrap.com. Accessed 20 June 2017.

28.

docker. http://www.docker.com. Accessed 20 June 2017.

29.

The uWSGI project. uwsgi-docs.readthedocs.org. Accessed 20 June 2017.

30.

NGINX. nginx.org. Accessed 20 June 2017.

31.

Global Angelman Syndrome Registry Patient Registration. https://angelmanregistry.info/rdrf/ang/register/. Accessed 20 June 2017.

Title: A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry
Authors: Kathryn R. Napier
Megan Tones
Chloe Simons
Helen Heussler
Adam A. Hunter
Meagan Cross
Matthew I. Bellgard
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Orphanet Journal of Rare Diseases / Issue 1/2017
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/s13023-017-0686-1

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2017

Developing and evaluating rare disease educational materials co-created by expert clinicians and patients: the paradigm of congenital hypogonadotropic hypogonadism

Unmet clinical needs and burden in Angelman syndrome: a review of the literature

Thalassemias in South Asia: clinical lessons learnt from Bangladesh

Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov

Normal sleep on mechanical ventilation in adult patients with congenital central alveolar hypoventilation (Ondine’s curse syndrome)

Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial